未有近視都唔可以掉以輕心！
點解小朋友6歲前要有遠視？
小朋友在3~4歲的時候，大概還會有150度以下的遠視。隨着眼球發育變長，遠視度數會越來越少。一直到16-18歲左右，眼球發展比較成熟時，度數才會穩定下來。尤其在6至12歲，眼球發育速度最快的階段，如果沒有保持著一定程度的遠視，度數就有可能快速增加變成近視。
假如小朋友6歲前已經沒有遠視，又沒有積極治療，每年加深速度可高達100度以上。如果小學一年級就已經有近視，等到小學畢業，按推算下會有600、700度左右的近視。阿托品眼藥水Atropine為目前
唯一有效預防近視的藥物。
4至9歲，沒有近視兒童
155名接受安慰劑
160名接受
0.05%阿托品
0.05%阿托品
每日滴一滴安慰劑兒童
兩年內出現近視比率高達53%2
每日滴一滴阿托品Atropine兒童
兩年內出現近視比率只有28%2
咁我本身有近視滴唔滴得阿托品Atropine眼藥水㗎？
緊係得！同埋你都快啲換咗你副普通近視眼鏡，如果唔係度數會愈嚟愈深！
咁點算呀？！
勿再戴普通近視眼鏡！
普通近視眼鏡主要功能是矯正中央視力，結構設計較為簡單。當在近距離用眼情況下(33厘米內)，普通近視眼鏡會將周邊光線聚焦在視網膜後，形成較大程度的遠視離焦，從而可令近視加深。對於小朋友在近視加深的高峰期，佩戴普通近視眼鏡對近視的控制或預防沒有太大幫助，因此近視控制眼鏡(離焦鏡)才能更有效預防及控制近視加深。
最有效的近視控制方案是混合治療
6至14歲是近視加深的高峰期
6-14歲是近視加深的高峰期，把握時機關注眼睛健康，可減慢近視加深速度。 隨著近視加深，有機會會演變成深近視，會大大增加患上嚴重眼疾的機會。近視800度以上的人患上嚴重眼疾的風險比正常人高，例如視網膜脫落，白內障，青光眼，黄班點病變等。激光矯視都無法減低風險，所以絕對要及早做好近視防控，防患未然。
立即預約
留下您的聯絡資料, 我們專人會盡快聯絡你。全面學童眼睛檢查及控制方案適用於6-17歲兒童。
備註
- Figure 2. Mean spherical equivalent refractive errors, as reported by several studies, plotted by age. A smooth curve (single exponential function) was plotted to illustrate the change in refractive error with age. Reprinted from Mayer, L., Hansen, R., Moore, B., Kim, S., Fulton, A., 2001. Cycloplegic refractions in healthy children aged 1 to 48 months. Arch. Ophthalmol. 119, 1625–1628.
- Yam JC, Zhang XJ, Zhang Y, et al. Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial. JAMA, Published February 14, 2023, doi: 10.1001/jama.2022.24162
- Yam, J. C., Jiang, Y., Tang, S. M., Law, A. K., Chan, J. J., Wong, E., ... & Pang, C. P. (2019). Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology, 126(1), 113-124.
- Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW (2023) A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLoS ONE 18(2): e0281816. https://doi.org/10.1371/journal.pone.0281816 Tan, Q., Ng, A. L., Cheng, G. P., Woo, V. C., & Cho, P. (2022). Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Contact Lens and Anterior Eye, 101723. .
- Tan, Q., Ng, A. L., Cheng, G. P., Woo, V. C., & Cho, P. (2022). Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Contact Lens and Anterior Eye, 101723.
- TBC
